The market seems to be pricing TSEM with sky-high expectations, as evidenced by its astronomical Price/Earnings ratio of over 107. Yet, the stock’s valuation is starkly misaligned with its DCF Value and Graham Number, suggesting a significant overvaluation. The Forward P/E of 32.05 reflects optimism for future earnings growth, but the Earnings Yield of just 0.93% is underwhelming. However, the Altman Z-score of 35.10 indicates robust financial health, mitigating bankruptcy risk. This juxtaposition of high valuation and financial safety creates a complex narrative for investors.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.